Slager David Mark 13D/13G Filings for Vascular Biogenics Ltd. (VBLT)

Slager David Mark 13D and 13G filings for Vascular Biogenics Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-01
4:20 pm
Purchase
2022-01-2413GVascular Biogenics Ltd.
VBLT
Slager David Mark101,545
5.130%
101,545increase
(New Position)
Filing